Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | Open Heart |
| Online Access: | https://openheart.bmj.com/content/7/2/e001350.full |